Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio Price : 3.99 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 4.03 | 4.115 | 3.945 | 3.99 | 3.087M |
| Nov 12, 2026 | 4.22 | 4.22 | 4.03 | 4.06 | 5.638M |
| Nov 11, 2026 | 4.27 | 4.38 | 4.22 | 4.29 | 2.952M |
| Nov 10, 2026 | 4.23 | 4.355 | 4.110 | 4.20 | 3.479M |
| Nov 09, 2026 | 4.23 | 4.43 | 4.075 | 4.35 | 5.327M |
| Nov 06, 2026 | 4.21 | 4.329 | 3.975 | 4.16 | 5.336M |
| Nov 05, 2026 | 4.459 | 4.81 | 4.18 | 4.19 | 8.424M |
| Nov 04, 2026 | 4.70 | 4.75 | 4.52 | 4.73 | 8.412M |
| Nov 03, 2026 | 4.62 | 4.785 | 4.61 | 4.69 | 5.145M |
| Nov 02, 2026 | 4.80 | 4.85 | 4.59 | 4.59 | 3.724M |
| Oct 30, 2026 | 4.75 | 4.805 | 4.60 | 4.76 | 5.064M |
| Oct 29, 2026 | 4.65 | 4.835 | 4.64 | 4.77 | 6.497M |
| Oct 28, 2026 | 4.48 | 4.60 | 4.425 | 4.59 | 5.216M |
| Oct 27, 2026 | 4.51 | 4.59 | 4.36 | 4.55 | 5.055M |
| Oct 26, 2026 | 4.62 | 4.68 | 4.48 | 4.51 | 3.663M |
| Oct 23, 2026 | 4.62 | 4.66 | 4.44 | 4.57 | 3.191M |
| Oct 22, 2026 | 4.83 | 4.91 | 4.655 | 4.70 | 5.805M |
| Oct 21, 2026 | 4.77 | 4.96 | 4.72 | 4.85 | 4.503M |
| Oct 20, 2026 | 4.51 | 4.82 | 4.46 | 4.77 | 6.853M |
| Oct 19, 2026 | 4.48 | 4.60 | 4.345 | 4.48 | 4.223M |
| Oct 16, 2026 | 4.75 | 4.76 | 4.42 | 4.45 | 4.473M |
| Oct 15, 2026 | 4.74 | 4.855 | 4.67 | 4.75 | 4.823M |
| Oct 14, 2026 | 4.66 | 4.80 | 4.61 | 4.68 | 3.780M |
| Oct 13, 2026 | 4.86 | 4.92 | 4.71 | 4.72 | 7.608M |
| Oct 12, 2026 | 4.96 | 5.005 | 4.88 | 4.90 | 3.183M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 28.89 |
| Johnson & Johnson | 285.75 |
| Merck & Co., Inc. | 147.76 |
| Bristol Myers Squibb Co. | 63.43 |
| ANI Pharmaceuticals, Inc. | 71.44 |
Price Related Metrics
| PS Ratio | 7.034 |
| Price to Book Value | 6.177 |
| Earnings Yield | -9.81% |
| Market Cap | 1.408B |